These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24269208)

  • 1. Comprehensive evaluation of etanercept stability in various concentrations with biophysical assessment.
    Kim NA; Lim DG; Lim JY; Kim KH; Jeong SH
    Int J Pharm; 2014 Jan; 460(1-2):108-18. PubMed ID: 24269208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of etanercept stability as exposed to various sugars with biophysical assessment.
    Lim DG; Kim NA; Lim JY; Kim KH; Hada S; Jeong SH
    Int J Pharm; 2014 Dec; 476(1-2):50-9. PubMed ID: 25269011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pH and buffer concentration on the thermal stability of etanercept using DSC and DLS.
    Kim NA; An IB; Lim DG; Lim JY; Lee SY; Shim WS; Kang NG; Jeong SH
    Biol Pharm Bull; 2014; 37(5):808-16. PubMed ID: 24790003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of analytical methods to detect instability of etanercept during thermal stress testing.
    Maarschalkerweerd Av; Wolbink GJ; Stapel SO; Jiskoot W; Hawe A
    Eur J Pharm Biopharm; 2011 Jun; 78(2):213-21. PubMed ID: 21272639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of etanercept degradation under oxidative stress and potential protective effects of various amino acids.
    Lim JY; Kim NA; Lim DG; Kim KH; Hada S; Jeong SH
    Int J Pharm; 2015 Aug; 492(1-2):127-36. PubMed ID: 26187168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biophysical evaluation of hybrid Fc fusion protein of hGH to achieve basal buffer system.
    Kim NA; An IB; Lim HS; Yang SI; Jeong SH
    Int J Pharm; 2016 Nov; 513(1-2):421-430. PubMed ID: 27659863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Product and process understanding to relate the effect of freezing method on glycation and aggregation of lyophilized monoclonal antibody formulations.
    Awotwe-Otoo D; Agarabi C; Read EK; Lute S; Brorson KA; Khan MA
    Int J Pharm; 2015 Jul; 490(1-2):341-50. PubMed ID: 25835267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperature-modulated noncovalent interaction controllable complex for the long-term delivery of etanercept to treat rheumatoid arthritis.
    Jung YS; Park W; Na K
    J Control Release; 2013 Oct; 171(2):143-51. PubMed ID: 23880471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
    Schüle S; Friess W; Bechtold-Peters K; Garidel P
    Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fundamental analysis of recombinant human epidermal growth factor in solution with biophysical methods.
    Kim NA; Lim DG; Lim JY; Kim KH; Jeong SH
    Drug Dev Ind Pharm; 2015 Feb; 41(2):300-6. PubMed ID: 24502269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical evaluation of Tm(FTIR) measurements of high-concentration IgG1 antibody formulations as a formulation development tool.
    Matheus S; Mahler HC; Friess W
    Pharm Res; 2006 Jul; 23(7):1617-27. PubMed ID: 16783474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of protein sub-visible particles during vacuum degassing of etanercept solutions.
    Wang H; Zheng HJ; Wang Z; Bai H; Carpenter JF; Chen S; Fang WJ
    Int J Biol Macromol; 2014 May; 66():151-7. PubMed ID: 24513220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution.
    Szenczi A; Kardos J; Medgyesi GA; Závodszky P
    Biologicals; 2006 Mar; 34(1):5-14. PubMed ID: 16168667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trifluoroethanol-induced conformational change of tetrameric and monomeric soybean agglutinin: role of structural organization and implication for protein folding and stability.
    Molla AR; Mandal DK
    Biochimie; 2013 Feb; 95(2):204-14. PubMed ID: 23022144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential exclusion mechanism by carbohydrates on protein stabilization using thermodynamic evaluation.
    Kim NA; Thapa R; Jeong SH
    Int J Biol Macromol; 2018 Apr; 109():311-322. PubMed ID: 29258899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of biophysical characterization techniques in predicting monoclonal antibody stability.
    Thiagarajan G; Semple A; James JK; Cheung JK; Shameem M
    MAbs; 2016; 8(6):1088-97. PubMed ID: 27210456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies.
    Brader ML; Estey T; Bai S; Alston RW; Lucas KK; Lantz S; Landsman P; Maloney KM
    Mol Pharm; 2015 Apr; 12(4):1005-17. PubMed ID: 25687223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregation of anti-streptavidin immunoglobulin gamma-1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration.
    Kim N; Remmele RL; Liu D; Razinkov VI; Fernandez EJ; Roberts CJ
    Biophys Chem; 2013 Feb; 172():26-36. PubMed ID: 23334430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine as a protein stabilizer and destabilizer in liquid formulations.
    Kim NA; Hada S; Thapa R; Jeong SH
    Int J Pharm; 2016 Nov; 513(1-2):26-37. PubMed ID: 27596112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of thermal and mechanical stress on the physical stability of human growth hormone and epidermal growth factor.
    Lim JY; Kim NA; Lim DG; Kim KH; Jeong SH
    Arch Pharm Res; 2015 Aug; 38(8):1488-98. PubMed ID: 25430693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.